Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical sciences, Tehran, Iran.
Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Adv Exp Med Biol. 2021;1341:89-105. doi: 10.1007/5584_2019_422.
Aging as an inevitable and complex physiological process occurs through a progressive decrease in the potential of tissue regeneration. Given the increasing global outbreak of aging and age-related disorders, it is important to control this phenomenon. Parkinson's disease (one of the age-related neurodegenerative and progressive disorders) resulted from predominant dopaminergic neurons deficiency. Usual Parkinson's disease treatments just can lead to symptomatically relieving. Recently, cell therapy and regenerative medicine a great promise in the treatment of several types of disorders including Parkinson's disease. Herein, before starting clinical trials, preclinical studies should be performed to answer some fundamental questions about the safety and efficacy of various treatments. Additionally, developing a well-designed and approved study is required to provide an appropriate animal model with strongly reliable validation methods. Hereupon, this review will discuss about the design and application of an appropriate Parkinson's disease animal model in regenerative medicine.
In order to conduct the present review, numbers of Parkinson's disease preclinical studies, as well as literatures related to the animal modeling, were considered.
Appropriate animal models which approved by related authorize committees should have a high similarity to humans from anatomical, physiological, behavioral, and genetic characteristics view of point.
It is concluded that animal studies before starting clinical trials have an important role in answering the crucial questions about the various treatments safety and efficacy. Therein, it is recommended that all of animal modeling stages be assessed by animal ethics and welfare guidelines and also evaluated by different validation tests. However, it is better to find some alternatives to replacement, refinement, and, reduction of animals. Nowadays, some novel technologies such as using imaging methods have been introduced.
衰老作为一个不可避免的复杂生理过程,是通过组织再生潜力的逐渐下降而发生的。鉴于老龄化和与年龄相关的疾病在全球范围内的爆发日益严重,控制这一现象至关重要。帕金森病(一种与年龄相关的神经退行性和进行性疾病之一)是由于多巴胺能神经元的明显缺失引起的。通常的帕金森病治疗只能导致症状缓解。最近,细胞疗法和再生医学在治疗多种疾病(包括帕金森病)方面有很大的希望。在此之前,在开始临床试验之前,应该进行临床前研究,以回答关于各种治疗方法的安全性和有效性的一些基本问题。此外,需要制定一个精心设计和批准的研究,为具有强烈可靠验证方法的适当动物模型提供支持。在此基础上,本文综述了再生医学中帕金森病动物模型的设计和应用。
为了进行本综述,考虑了许多帕金森病临床前研究以及与动物模型相关的文献。
从解剖学、生理学、行为和遗传特征的角度来看,经相关授权委员会批准的适当动物模型应与人类高度相似。
临床试验前的动物研究在回答各种治疗方法的安全性和有效性的关键问题方面具有重要作用。在此,建议所有动物建模阶段都应根据动物伦理和福利指南进行评估,并通过不同的验证测试进行评估。然而,最好寻找一些替代方法来替代、改进和减少动物。如今,已经引入了一些新技术,如使用成像方法。